Entropy’s founder has shut down the crypto startup and announced a strategic pivot away from blockchain toward the pharmaceutical sector. The decision follows challenging market conditions and reduced funding appetite for crypto ventures. The founder said lessons from building in crypto will inform the new focus, which aims to apply data-driven and technological approaches to drug development and healthcare innovation. The move reflects a broader trend of entrepreneurs exiting crypto to pursue opportunities in more stable, regulation-driven industries.